Cargando…
Neuroprotective Strategies for Traumatic Brain Injury: Improving Clinical Translation
Traumatic brain injury (TBI) induces secondary biochemical changes that contribute to delayed neuroinflammation, neuronal cell death, and neurological dysfunction. Attenuating such secondary injury has provided the conceptual basis for neuroprotective treatments. Despite strong experimental data, mo...
Autores principales: | Kabadi, Shruti V., Faden, Alan I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907865/ https://www.ncbi.nlm.nih.gov/pubmed/24445258 http://dx.doi.org/10.3390/ijms15011216 |
Ejemplares similares
-
Selective CDK inhibitors: promising candidates for future clinical traumatic brain injury trials
por: Kabadi, Shruti V., et al.
Publicado: (2014) -
Cell cycle inhibition reduces inflammatory responses, neuronal loss, and cognitive deficits induced by hypobaria exposure following traumatic brain injury
por: Skovira, Jacob W., et al.
Publicado: (2016) -
Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?
por: Lerouet, Dominique, et al.
Publicado: (2021) -
The Neuroprotective and Biomarker Potential of PACAP in Human Traumatic Brain Injury
por: Toth, Denes, et al.
Publicado: (2020) -
Neuroprotection in acute brain injury: an up-to-date review
por: Stocchetti, Nino, et al.
Publicado: (2015)